Effects of pentoxifylline administration on urinary N-acetyl-β-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study
- 31 August 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 42 (2) , 264-270
- https://doi.org/10.1016/s0272-6386(03)00651-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- EFFECT OF PENTOXIFYLLINE ON ISCHEMIC ACUTE RENAL FAILURE IN RABBITSRenal Failure, 2001
- Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administrationAmerican Journal of Kidney Diseases, 1999
- Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-upDiabetes Care, 1998
- Can pentoxifylline prevent renal disease?Renal Failure, 1998
- Increased urinary N-acetyl-β-glucosaminidase (NAG) excretion in young insulin-dependent diabetic patientsDiabetes Research and Clinical Practice, 1995
- Effect of pentoxifylline on CdCl2-induced nephrotoxicity in the ratBiological Trace Element Research, 1994
- Enzymuria in Non-Insulin-Dependent Diabetic Patients: Signs of Tubular Cell DysfunctionClinical Science, 1993
- Pentoxifylline in Management of Proteinuria in Diabetic NephropathyNephron, 1993
- A Six‐year Follow‐up of the Relationship Between N‐Acetyl‐β‐glucosaminidase and Albuminuria in Relation to RetinopathyDiabetic Medicine, 1991
- PentoxifyllineDrugs, 1987